Modified super-long down-regulation protocol improves fertilization and pregnancy in patients with poor ovarian responses

Chinese Medical Journal

Volumn 125, Issue 16, 2012, Pages 2837-2840

  Zhang, Hui juan ^a   Song, Xue ru ^a   Rui, Lü ^a   Xue, Feng xia ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Controlled ovarian hyperstimulation; In vitro fertilization; Modified super long down regulation protocol; Poor responder; Routine long protocol

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; RECOMBINANT CHORIONIC GONADOTROPIN; TRIPTORELIN;

ADULT; ARTICLE; ARTIFICIAL INSEMINATION; COMPARATIVE STUDY; DOSAGE SCHEDULE COMPARISON; ECHOGRAPHY; EMBRYO; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FETUS HEART RATE; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; OOCYTE CLEAVAGE; OOCYTE RETRIEVAL; OUTCOME ASSESSMENT; OVARY HYPERSTIMULATION; PREGNANCY RATE; TREATMENT RESPONSE;

ADULT; CHORIONIC GONADOTROPIN; EMBRYO TRANSFER; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HUMANS; MALE; OVULATION INDUCTION; PREGNANCY;

EID: 84865378885     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2012.16.007     Document Type: Article

References (21)

1. Ulug U, Ben-Shlomo I, Turan E, Erden HF, Akman MA, Bahceci M. Conception rates following assisted reproduction in poor responder patients: a retrospective study in 300 consecutive cycles. Reprod Biomed Online 2003; 6: 439-443.
2. Frattarelli JL, Hill MJ, McWilliams GD, Miller KA, Bergh PA, Scott RT Jr. A luteal estradiol protocol for expected poor-responders improves embryo number and quality. Fertil Steril 2008; 89: 1118-1122.
3. Fasouliotis S, Simon A, Laufer N. Evaluation and treatment of low responders in assisted reproductive technology: a challenge to meet. J Assist Reprod Gen 2000; 17: 357-373.
4. Hellberg D, Waldenstrom U, Nilsson S. Defining a poor responder in in vitro fertilization. Fertil Steril 2004; 82: 488-490.
5. Surrey ES, Schoolcraft WB. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil Steril 2000; 73: 667-676.
6. Coccia ME, Rizzello F, Mariani G, Bulletti C, Palagiano A, Scarselli G. Impact of endometriosis on IVF-ET cycles in young women: a stage dependent interference. Acta Obstet Gynecol Scand 2011; 90: 1232-1238.
7. Padhy N, Gupta S, Mahla A, Latha M, Varma T. Demographic characteristics and clinical profile of poor responders in IVF /ICSI: A comparative study. J Hum Reprod Sci 2010; 3: 91-94.
8. Lashen H, Ledger W, Lopez-Bernal A, Barlow D. Poor responders to ovulation induction: is proceeding to in-vitro fertilization worthwhile. Hum Reprod 1999; 14: 964-969.
9. Pu D, Wu J, Liu J. Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF. Hum Reprod 2011; 26: 2742-2749.
10. Marci R, Caserta D, Dolo V, Tatone C, Pavan A, Moscarini M. GnRH antagonist in IVF poor-responder patients: results of a randomized trial. Reprod Biomed Online 2005; 11: 189-193.
11. Mohamed KA, Davies WA, Lashen H. Effect of gonadotropin-releasing hormone agonist and antagonist on steroidogenesis of low responders undergoing in vitro fertilization. Gynecol Endocrinol 2006; 22: 57-62.
12. Demirol A, Gurgan T. Comparison of microdose flare-up and antagonist multiple-dose protocols for poor-responder patients: a randomized study. Fertil Steril 2009; 92: 481-485.
13. Kahraman K, Berker B, Atabekoglu CS, Sonmezer M, Cetinkaya E, Aytac R, et al. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle. Fertil Steril 2009; 91: 2437-2444.
14. Malmusi S, La Marca A, Giulini S, Xella S, Tagliasacchi D, Marsella T, et al. Comparison of a gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare-up regimen in poor responders undergoing ovarian stimulation. Fertil Steril 2005; 84: 402-406.
15. Smulders B, van Oirschot SM, Farquhar C, Rombauts L, Kremer JA. Oral contraceptive pill, progestogen or estrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques. Cobrane Database Syst Rev 2010; 20; CD006109.
16. Tesarik J, Hazout A, Mendoza C. Improvement of delivery and live birth rates after ICSI in women aged >40 years by ovarian co-stimulation with growth hormone. Hum Reprod 2005; 20: 2536-2541.
17. Wiser A, Gonen O, Ghetler Y, Shavit T, Berkovitz A, Shulman A. Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: A randomized prospective study. Hum Reprod 2010; 25: 2496-2500.
18. Feigenberg T, Simon A, Ben-Meir A, Gielchinsky Y, Laufer N. Role of androgens in the treatment of patients with low ovarian response. Reprod Biomed Online 2009; 19: 888-898.
19. Massin N, Cedrin-Durnerin I, Coussieu C, Galey-Fontaine J, Wolf JP, Hugues JN. Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique--a prospective, randomized, double-blind study. Hum Reprod 2006; 21: 1204-1211.
20. Wilcox J, Potter D, Moore M, Ferrande L, Kelly E. Prospective, randomized trial comparing cetrorelix acetate and ganirelix acetate in a programmed, flexible protocol for premature luteining hormone surge prevention in assisted reproductive technologies. Fertil Steril 2005; 84: 108-117.
21. Mendoza C, Cremades N, Ruiz-Requena E, Martinez F, Ortega E, Bernabeu S, et al. Relationship between fertilization results after intracytoplasmic sperm injection, and intrafollicular steroid, pituitary hormone and cytokine concentrations. Hum Reprod 1999; 14: 628-635.